1316756-72-5

Upstream product

• 1316756-68-9 ethyl (2E,6R,7S)-6-[bis(cyclopentylmethyl)amino]-7-hydroxy-7-[4-(trifluoromethyl)phenyl]hept-2-enoate 
• 1316756-67-8 ethyl (2E,6R)-6-[bis(cyclopentylmethyl)amino]-7-oxohept-2-enoate 
• 1316756-66-7 ethyl (2E,6R)-6-[bis(cyclopentylmethyl)amino]-7-hydroxyhept-2-enoate 
• 1316756-65-6 ethyl (2E,6R)-6-amino-7-hydroxyhept-2-enoate 
• 1316756-64-5 tert-butyl (4R)-4-[(3E)-5-ethoxy-5-oxopent-3-en-1-yl]-2,2-dimethyl-1,3-oxazolidine-3-carboxylate 
• 146398-08-5 methyl 4-<(tert-butyloxycarbonyl)amino>-5-hydroxypentanoate 
• 149180-92-7 (R)-tert-butyl 2,2-dimethyl-4-(3-oxopropyl)oxazolidine-3-carboxylate 
• 1316756-63-4 tert-butyl (4R)-4-(3-methoxy-3-oxopropyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate 
• 45214-91-3 N-α-(tert-butoxycarbonyl)-D-glutamic acid γ-methyl ester 

Relevant academic research and scientific papers

AMINOCYCLOHEXANES AND AMINOTETRAHYDROPYRANS AND RELATED COMPOUNDS AS GAMMA-SECRETASE MODULATORS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.